Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Fraietta

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|May 8, 2026
PSCA CAR Vδ1 T cells: a safer off-the-shelf CAR T therapy for pancreatic cancer?Joseph A Fraietta, Jason J Lohmueller
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2021
BETting on BRD4 inhibition to combat adaptive resistance to CAR T cell therapy in glioblastomaCaitlin R Hopkins, Joseph A Fraietta
Trends in Molecular Medicine|June 16, 2020
First Trial of CRISPR-Edited T cells in Lung CancerSimon F Lacey, Joseph A Fraietta
Molecular Cancer|March 19, 2022
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editingAlexander Dimitri, Friederike Herbst, Joseph A Fraietta
Cytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A Fraietta
Discovery Medicine|January 14, 2014
Immunotherapy with chimeric antigen receptors for multiple myelomaAlfred L Garfall, Joseph A Fraietta, Marcela V Maus
Seminars in Oncology|April 5, 2016
Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cellsJoseph A Fraietta, Robert D Schwab, Marcela V Maus
Biomarkers in Medicine|April 27, 2018
Biomarkers in chimeric antigen receptor T-cell therapyWeimin Kong, Simon F Lacey, Jan Joseph Melenhorst, et al.
Seminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.
American Journal of Hematology|January 26, 2019
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancerSteven Feins, Weimin Kong, Erik F Williams, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|May 8, 2026
PSCA CAR Vδ1 T cells: a safer off-the-shelf CAR T therapy for pancreatic cancer?Joseph A Fraietta, Jason J Lohmueller
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2021
BETting on BRD4 inhibition to combat adaptive resistance to CAR T cell therapy in glioblastomaCaitlin R Hopkins, Joseph A Fraietta
Trends in Molecular Medicine|June 16, 2020
First Trial of CRISPR-Edited T cells in Lung CancerSimon F Lacey, Joseph A Fraietta
Molecular Cancer|March 19, 2022
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editingAlexander Dimitri, Friederike Herbst, Joseph A Fraietta
Cytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A Fraietta
Discovery Medicine|January 14, 2014
Immunotherapy with chimeric antigen receptors for multiple myelomaAlfred L Garfall, Joseph A Fraietta, Marcela V Maus
Seminars in Oncology|April 5, 2016
Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cellsJoseph A Fraietta, Robert D Schwab, Marcela V Maus
Biomarkers in Medicine|April 27, 2018
Biomarkers in chimeric antigen receptor T-cell therapyWeimin Kong, Simon F Lacey, Jan Joseph Melenhorst, et al.
Seminars in Immunology|September 20, 2023
Beyond youth: Understanding CAR T cell fitness in the context of immunological agingJulia Han Noll, Bruce L Levine, Carl H June, et al.
American Journal of Hematology|January 26, 2019
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancerSteven Feins, Weimin Kong, Erik F Williams, et al.
Pageof 11